The successes of newer obesity medications and metabolic–bariatric surgeries derive from their ability to interfere with the enhanced biological signals promoting food intake normally elicited as part of the homeostatic adaptation response to weight loss, including alterations in meal‐related gut hormone release and leptin levels. This evidence concerns the gene LEP and Obesity.